« Zurück
Startseite /
Research Area /
Oncology /
Recombinant Human DR5/TRAIL R2 Protein (His Tag), HPLC-verified

Recombinant Human DR5/TRAIL R2 Protein (His Tag), HPLC-verified

ArtNr	10465-H08H-4
Hersteller	Sino Biological
Menge	4 mg
Quantity options	1 mg 100 ug 2 mg 4 mg
Kategorie	Oncology By Cell Type Carcinoma Hematology Myeloma Peptides & Proteins Recombinant Proteins Cell Biology Cell Status Apoptosis
Typ	Proteins
Specific against	Human (Homo sapiens)
Host	Human
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9
Similar products	TNFRSF10B
Lieferbar
Manufacturer - Category	Protein
Molecule	TNFRSF10B
Synonym	CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9
Storage	Store it under sterile conditions at -20C to -80C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Shipping	In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Protein Construction	A DNA sequence encoding the human TNFRSF10B (NP_003833.3) extracellular domain (Met 1-Glu 182) was expressed, fused with a polyhistidine tag at the C-terminus.
Expressed Host	Human Cells
Purity	> 95 % as determined by SDS-PAGE
Bio-Activity	1. Measured by its binding ability in a functional ELISA. Immobilized human TNFRSF10B at 10 ug/ml (100 ul/well) can bind biotinylated TNFSF10 with a linear range of 0.625-20 ng/ml. 2. Measured by its ability to inhibit TRAIL-mediated cytotoxicity using L?929 mouse fibroblast cells treated with TRAIL. The ED50 for this effect is typically 0.025-0.275 ug/mL in the presence of 20 ng/ml Recombinant Human TRAIL/TNFSF10.
Endotoxin	< 1.0 EU per ug of the protein as determined by the LAL method
Predicted N Terminal	Ile 56
Molecule Mass	The recombinant human TNFRSF10B consists of 138 amino acids and has a predicted molecular mass of 15.8 kDa. As a result of glycosylation, the apparent molecular mass of rhTNFRSF10B is approxiamtely 20-22 kDa in SDS-PAGE under reducing conditions.
Formulation	Lyophilized from sterile PBS, pH 7.4
Accession	NP_003833.3
Amino acid sequence	Met1-Glu182
TAG	C-His

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

10465-H08H-4-datasheet.pdf

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: 4 mg

lieferbar

Technische Frage stellen